Efficacy and safety of dabigatran compared with warfarin in patients with atrial fibrillation in relation to renal function over time-A RE-LY trial analysis

Am Heart J. 2018 Apr;198:169-177. doi: 10.1016/j.ahj.2017.10.015. Epub 2018 Jan 5.
No abstract available

Publication types

  • Comparative Study
  • Multicenter Study
  • Randomized Controlled Trial
  • Research Support, Non-U.S. Gov't

MeSH terms

  • Aged
  • Anticoagulants / administration & dosage*
  • Anticoagulants / adverse effects
  • Atrial Fibrillation / diagnostic imaging
  • Atrial Fibrillation / drug therapy*
  • Atrial Fibrillation / mortality*
  • Cause of Death
  • Dabigatran / administration & dosage*
  • Dabigatran / adverse effects
  • Double-Blind Method
  • Female
  • Follow-Up Studies
  • Glomerular Filtration Rate / drug effects
  • Humans
  • Internationality
  • Kaplan-Meier Estimate
  • Kidney Function Tests
  • Male
  • Middle Aged
  • Proportional Hazards Models
  • Risk Assessment
  • Stroke / prevention & control*
  • Survival Analysis
  • Time Factors
  • Treatment Outcome
  • Warfarin / administration & dosage*
  • Warfarin / adverse effects

Substances

  • Anticoagulants
  • Warfarin
  • Dabigatran

Associated data

  • ClinicalTrials.gov/NCT00262600